Feeblin Options
in the mouse product, providing genetic validation of CRK12:CYC9 to be a novel drug target for trypanosomiasis. More, useful characterisation of CRK12 and CYC9 applying RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively., et al Loss of MAP3K7 sensitizes prostate most cancers cells to CDK1/2 inhibition and